[ASND] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
18-Aug-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -10.33%
YoY- -85.59%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 2,757 2,243 20 434 1,169 2,117 3,250 -2.70%
PBT -121,760 -25,174 -34,067 -34,117 -18,311 -7,470 -1,931 99.37%
Tax -19 -61 -100 -240 -57 -160 49 -
NP -121,741 -25,113 -33,967 -33,877 -18,254 -7,310 -1,980 98.54%
Tax Rate - - - - - - - -
Total Cost 124,498 27,356 33,987 34,311 19,423 9,427 5,230 69.52%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -4,415.71 -1,119.62 -169,835.00 -7,805.76 -1,561.51 -345.30 -60.92 104.05%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -2.31 -0.53 -0.81 -1.04 -0.72 -0.30 -0.12 63.63%
EPS Diluted -2.31 -0.53 -0.81 -1.04 -0.72 -0.30 -0.12 63.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.